Breast cancer in black women

Annals of Internal Medicine

Volumn 124, Issue 10, 1996, Pages 897-905

  Moormeier, Jill ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

BREAST CANCER; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; EARLY DIAGNOSIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; NEGRO; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR;

EID: 0029974853     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-10-199605150-00007     Document Type: Review

References (98)

1. Miller BA, Gloeckler Ries LA. Hankey BF. Kosary CL, Harras A, Devesa SS, et al. Annual cancer statistics review SEER Program Washington, DC: National Cancer Advisory Board, 1993 NIH publication no 93-2789
2. Boring CC, Squires TS, Tong T. Montgomery S. Cancer statistics, 1994 CA Cancer J Clin. 1994,44.7-26.
3. Austin H, Cole P, Wynder E. Breast cancer in black American women Int J Cancer. 1979,24 541-4.
4. Schatzkin A, Palmer JR. Rosenberg L, Helmrich SP, Miller DR, Kaufman DW, et al. Risk factors for breast cancer in black women J Natl Cancer Inst. 1987;78 213-7
5. Mayberry RM, Stoddard-Wright C. Breast cancer risk factors among black women and white women. similarities and differences. Am J Epidemiol 1992, 136:1445-56.
6. Devesa SS, Diamond EL Association of breast cancer and cervical cancer incidence with income and education among whites and blacks. J Natl Cancer Inst 1980,65 515-28
7. Krieger N. Social class and the black/white crossover in the age-specific incidence of breast cancer: a study linking census-derived data to populationbased registry records. Am J Epidemiol 1990;131:804-14
8. McWhorter WP, Schatzkin AG, Horm JW, Brown CC Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer 1989,63 982-7
9. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993,15.36-47
10. MacMahon B. Age at menarche Vital Health Stat 1973;11-11-27
11. MacMahon B, Worcester J. Age at menopause. United States - 1960-1962. Vital Health Stat. 1966,11.1-20
12. Spratley E. Birth and fertility rates for states and metropolitan areas United States Vital Health Stat 1977,27.1-45
13. Gray GE, Henderson BE, Pike MC Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States J Natl Cancer Inst. 1980;64-461-3.
14. Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 1994,331:5-9.
15. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk Epidemiol Rev 1993, 15 17-35.
16. Thomas DB. Oral contraceptives and breast cancer J Natl Cancer Inst. 1993; 85:359-64
17. Dawson DA. Trends in use of oral contraceptives - data from the 1987 National Health Interview Survey Family Plan Perspect 1990;22:169-72
18. Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer Arch Intern Med 1991;151:67-72.
19. Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991,265 1985-90
20. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women N Engl J Med. 1996;332:1589-93.
21. Amos CI, Goldstein AM, Harris EL. Familiality of breast cancer and socioeconomic status in blacks Cancer Res 1991,51 1793-7
22. Schwartz AG, Kaufmann R, Moll PP. Heterogeneity of breast cancer risk in families of young breast cancer patients and controls. Am J Epidemiol 1991, 134:1325-34.
23. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, et al. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians JAMA 1995;273.577-85.
24. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene Implications for presymptomatic testing and screening JAMA. 1995,273 535-41.
25. Chamberlain JS, Boehnke M. Frank TS, Kiousis S, Xu J, Guo SW, et al. BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis Am J Hum Genet 1993,52:792-8
26. Bodian CA. Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev 1993,15.177-87.
27. Garber JE, Henderson IC, Love SM, Gelman RS. Management of high risk groups In. Harris JR, Hellman S, Henderson IC, Kinne DW, eds. Breast Diseases 2d ed Philadelphia JB Lippincott, 1991:152-63
28. Funderburk WW, Rosero E, Leffall LD. Breast lesions in blacks Surg Gynecol Obstet. 1972,135 58-60.
29. Oluwole SF, Freeman HP. Analysis of benign breast lesions in blacks Am J Surg 1979,137:786-9
30. Organ CH Jr, Organ BC. Fibroadenoma of the female breast a critical clinical assessment J Natl Med Assoc 1983,75:701-4
31. Kovi J, Mohla S, Norris HJ, Sampson CC, Heshmat MY. Breast lesions in black women Pathol Annu. 1989;24(Pt 1):199-218
32. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 1993,85 1644-56
33. Black Americans' attitudes toward cancer and cancer tests: highlights of a study CA Cancer J Clin 1981;31 212-8
34. Caplan LS, Wells BL Haynes S. Breast cancer screening among older racial/ethnic minorities and whites barriers to early detection J Gerontol. 1992,47.101-10.
35. Lackland DT, Dunbar JB, Keil JE, Knapp RG, O'Brien PH. Breast cancer screening in a biracial community the Charleston tricounty experience South Med J. 1991,84.862-6
36. O'Malley MS, Fletcher SW. US Preventive Services Task Force Screening for breast cancer with breast self-examination. A critical review. JAMA 1987, 257:2196-203
37. Hayward RA, Shapiro MF, Freeman HE, Corey CR. Who gets screened for cervical and breast cancer? Results from a new national survey Arch Intern Med 1988,148 1177-81
38. Makuc DM, Freid VM, Kleinman JC. National trends in the use of preventive health care by women Am J Public Health 1989;79.21-6
39. Katz SJ, Hofer TP. Socioeconomic disparites in preventive care persist despite universal coverage Breast and cervical cancer screening in Ontario and the United States JAMA 1994,272.530-4
40. Lane DS, Polednak AP. Burg MA. Breast cancer screening practices among users of county-funded health centers vs women in the entire community. Am J Public Health 1992,82.199-203
41. Calle EE, Flanders D, Thun MJ, Martin LM. Demographic predictors of mammography and Pap smear screening in US women. Am J Public Health 1993,83 53-60.
42. Ackermann SP, Brackbill RM, Bewerse BA, Sanderson LM. Cancer screening behaviors among US. women, breast cancer, 1987-1989, and cervical cancer, 1988-1989 MMWR CDC Surveill Summ 1992,41:17-25.
43. Fletcher SW, Harris RP, Gonzalez JJ, Degnan D, Lannin DR, Strecher VJ, et al. Increasing mammography utilization. a controlled study J Natl Cancer Inst 1993,85 112-20
44. Burack RC, Liang J. The acceptance and completion of mammography by older black women. Am J Public Health. 1989,79:721-6.
45. Vernon SW, Vogel VG, Halabi S, Jackson GL, Lundy RO, Peters GN. Breast cancer screening behaviors and attitudes in three racial/ethnic groups Cancer. 1992,69.165-74
46. Kiefe CI, McKay SV, Halevy A, Brody BA. Is cost a barrier to screening mammography for low-income women receiving Medicare benefits? A randomized trial. Arch Intern Med 1994,154:1217-24
47. Mandelblatt J, Traxler M, Lakin P, Kanetsky P, Thomas L, Chauhan P, et al. Breast and cervical cancer screening of poor, elderly, black women: clinical results and implications Harlem Study Team Am J Prev Med 1993; 9 133-8.
48. Skinner CS, Strecher VJ, Hospers H. Physicians' recommendations for mammography do tailored messages make a difference? Am J Public Health 1994;84.43-9
49. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer. Results of a national survey by the American College of Surgeons Cancer 1980,45 2917-24.
50. Ownby HE, Frederick J, Russo J, Brooks SC, Swanson GM, Heppner GH, et al. Racial differences in breast cancer patients. J Natl Cancer Inst 1985,75.55-60.
51. Natarajan N, Nemoto T, Mettlin C, Murphy GP. Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons Cancer 1985;56:1704-9
52. Bain RP, Greenberg RS, Whitaker JP. Racial differences in survival of women with breast cancer J Chronic Dis. 1986;39 631-42
53. Coates RJ, Clark WS, Eley JW, Greenberg RS, Huguley CM Jr, Brown RL. Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst. 1990,82 1684-92.
54. Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, et al. Breast cancer: factors associated with stage at diagnosis in black and white women Black/White Cancer Survival Study Group J Natl Cancer Inst. 1993;85:1129-37
55. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States J Natl Cancer Inst. 1994;86:705-12
56. Gordon NH, Crowe JP, Brumberg DJ, Berger NA. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol. 1992,135: 609-18.
57. Swanson GM, Satariano ER, Satariano WA, Threatt BA. Racial differences in the early detection of breast cancer in metropolitan Detroit, 1978 to 1987. Cancer. 1990,66:1297-301
58. Simon MS, Schwartz AG, Martino S, Swanson GM. Trends in the diagnosis of in situ breast cancer in the Detroit metropolitan area, 1973 to 1987 Cancer 1992,69.466-9
59. Swanson GM, Ragheb NE, Lin CS, Hankey BF. Miller B, Horn-Ross P, et al. Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age, and extent of disease Cancer. 1993,72.788-98.
60. Bacquet CR, Ringen K, Pollack ES, Young JL, Horm JW, Gloeckler Ries LA. Cancer among blacks and other minorities. statistical profiles. Bethesda, MD: National Cancer Institute; 1986, NIH publication no. 86-2785
61. Freeman HP, Wasfie TJ. Cancer of the breast in poor black women. Cancer. 1989,63 2562-9.
62. Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D. et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1994;3:127-35.
63. Lesser ML, Rosen PP, Senie RT, Duthie K, Menendez-Botet C, Schwartz MK. Estrogen and progesterone receptors in breast carcinoma correlations with epidemiology and pathology. Cancer 1981,48:299-309.
64. Savage N, Levin J, De Moor NG, Lange M. Cytosolic oestrogen receptor content of breast cancer tissue in blacks and whites S Afr Med J 1981,59. 623-4
65. Pegoraro RJ, Karnan V, Nirmul D, Joubert SM. Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res. 1986;46(4 Pt 2) 2117-20.
66. Beverly LN, Flanders WD, Go RC, Soong SJ. A comparison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Public Health 1987,77 351-3
67. Mohla S, Sampson CC, Khan T, Enterline JP, Leffall L Jr, White JE. Estrogen and progesterone receptors in breast cancer in Black Americans: Correlation of receptor data with tumor differentiation. Cancer 1982,50 552-9.
68. Farley TA, Flannery JT. Late-stage diagnosis of breast cancer in women of lower socioeconomic status. public health implications. Am J Public Health. 1989;79:1508-12
69. Wells BL, Horm JW. Stage at diagnosis in breast cancer. race and socioeconomic factors. Am J Public Health. 1992;82.1383-5.
70. Mandelblatt J, Andrews H, Kemer J, Zauber A, Burnett W. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type Am J Public Health. 1991,81:646-9.
71. Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer N Engl J Med 1993,329:326-31.
72. Access of Medicaid recipients to outpatient care N Engl J Med. 1994,330: 1426-30
73. Vernon SW, Tilley BC, Neale AV, Steinfeldt L. Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer 1985;55. 1563-71
74. Coates RJ, Bransfield DD, Wesley M, Hankey B, Eley JW, Greenberg RS, et al. Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group J Natl Cancer Inst. 1992;84:938-50
75. McWhorter WP, Mayer WJ. Black/white differences in type of initial breast cancer treatment and implications for survival Am J Public Health 1987,77: 1515-7
76. Muss HB, Hunter CP, Wesley M, Correa P, Chen VW, Greenberg RS, et al. Treatment plans for black and white women with stage II node-positive breast cancer The National Cancer Institute Black/White Cancer Survival Study experience Cancer 1992;70:2460-7
77. Pierce L, Fowble B, Solin LJ, Schultz DJ, Rosser C, Goodman RL Conservative surgery and radiation therapy in black women with early stage breast cancer Patterns of failure and analysis of outcome Cancer 1992,69. 2831-41.
78. Diehr P, Yergan J, Chu J, Feigl P, Glaefke G, Moe R, et al. Treatment modality and quality differences for black and white breast-cancer patients treated in community hospitals. Med Care 1989;27 942-58
79. Zelen M, Betensky R, Gelman R. Black vs. white survival in clinical trials. The ECOG experience. Proceedings of the American Society of Clinical Oncology 1990;9:59.
80. Kimmick G, Muss HB, Case LD. Stanley V. A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer The Piedmont Oncology Association experience. Cancer. 1991,67.2850-4.
81. Elias EG, Suter CM, Brown SD, Buda BS, Vachon DA. Survival differences between black and white women with breast cancer. J Surg Oncol 1994;55: 37-41.
82. Eley JW, Hill HA, Chen VW. Austin DF, Wesley MN, Muss HB, et al. Racial differences in survival from breast cancer Results of the National Cancer Institute Black/White Cancer Survival Study JAMA. 1994;272:947-54
83. Crowe JP Jr. Gordon NH, Hubay CA, Pearson OH, Marshall JS, McGuire WL The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patients Surgery 1986;100:599-605
84. Contesso G, Mouriesse H, Friedman S, Genin J, Sarrazin D, Rouesse J. The importance of histologic grade in long-term prognosis of breast cancer a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy J Clin Oncol 1987;5 1378-86
85. Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M. Prognostic value of histologic grade nuclear components of Scarff-Bioom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas Cancer. 1989, 64.1914-21.
86. 0) breast carcinoma. a study of 644 patients with median follow-up of 18 years J Clin Oncol. 1989,7:1239-51
87. Neville AM, Bettelheim R, Gelber RD. Säve-Söderbergh J, Davis BW, Reed R, et al. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group J Clin Oncol 1992,10 696-705.
88. Chevallier B, Heintzmann F, Mosseri V, Dauce JP, Bastit P, Graic Y, et al. Prognostic value of estrogen and progesterone receptors in operable breast cancer Results of univanate and multivariate analysis. Cancer. 1988; 62:2517-24
89. Huseby RA, Ownby HE, Frederick J. Brooks S, Russo J, Brennan MJ. Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies variables associated with disease recurrence and survivorship J Clin Oncol 1988,6.83-8.
90. Clark GM, Dressler LG, Owens MA, Pounds G. Oldaker T, McGuire WL. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry N Engl J Med. 1989,320:627-33
91. Sigurdsson H, Baldetorp B, Borg Å, Dalberg M, Fernö M, Killander D, et al. Indicators of prognosis in node-negative breast cancer N Engl J Med 1990;322 1045-53
92. Garrett PA, Hulka BS, Kim YL, Farber RA. HRAS protooncogene polymorphism and breast cancer Cancer Epidemiol Biomarkers Prev 1993,2:131-8.
93. Blaszyk H, Vaughn CB, Hartmann A. McGovem RM, Schroeder JJ, Cunningham J, et al. Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer Lancet 1994,343 1195-7
94. Shiao YH, Chen VW, Scheer WD, Wu XC, Correa P. Racial disparity in the association of p53 gene alterations with breast cancer survival Cancer Res 1995;55.1485-90
95. Berg JW, Ross R, Latourette HB. Economic status and survival of cancer patients. Cancer 1977,39 467-77.
96. Sutherland CM, Mather FJ. Long-term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, or chest wall attachment) disease with and without positive lymph nodes Cancer 1986;57.622-9
97. Dayal HH, Power RN, Chiu C. Race and socio-economic status in survival from breast cancer J Chronic Dis 1982,35 675-83
98. Bassett MT, Krieger N. Social class and black-white differences in breast cancer survival Am J Public Health 1986,76 1400-3